Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
McGill University
$120,000.00
Towards a new gold standard battery for the cost-effective early detection and monitoring of underlying core Alzheimer's disease biomarkers using state-of-the-art measures of objective language impairments.
FY 2025-26
Summary
It has been estimated that nearly 1 million Canadians will be living with dementia by 2031. Alzheimer's disease, its most common cause, begins to develop silently and over decades before clear symptoms arise, and today, nearly half of Alzheimer's cases remain unidentified until the latest stages of disease development. One promising early warning sign is a worry expressed by many older adults over their perceived decline in abilities to find words. Until recently, these complaints were brushed off as signs of normal aging. However, new research shows that these "word-finding" difficulties may in fact be linked to early changes in the brain associated with Alzheimer's disease.
Unfortunately, the tools most commonly used in clinical practice are unable to capture subtle changes in language abilities. They often only rely on whether or not a person is able to give a correct answer, neglecting to account, for example, the time taken to get there.
To address existing limitations, our project aims to assemble existing state-of-the-art tasks of language measurement and combine them into a single, gold standard battery which we will promote the use of in clinical practice. It will be aimed at detecting subtle changes in speech and naming abilities, adapting in real time to performance and will be completable on a tablet and provide instantaneous results.
Over the next five years, we will develop this new tool and examine its performance and attributes in comparison to existing methods and self-reported concerns, notably how accurately it can detect underlying brain changes linked to Alzheimer's disease.
Our work will result in a freely available, scientifically validated, gold standard method to detect and monitor Alzheimer's disease at its earliest stages of development. When interventions are most likely to make a difference. This new tool should return power to clinicians, but more importantly, older adults expressing concerns about their perceived declining abilities.
Department
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
560267
Name
Marier Anna
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Clinical
Prcname2
DT2 (Health services and population health research) CGRS Doctoral
Projecttitle
Towards a new gold standard battery for the cost-effective early detection and monitoring of underlying core Alzheimer's disease biomarkers using state-of-the-art measures of objective language impairments.
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Alzheimer'S Core Biomarkers; Alzheimer'S Disease Continuum; Connected Speech Features; Digital And Adaptive; Famous People Naming; Neuropsychology; Psychometric Properties; Rapid Confrontation Naming; Subjective Word-Finding Complaints
Abstract
It has been estimated that nearly 1 million Canadians will be living with dementia by 2031. Alzheimer's disease, its most common cause, begins to develop silently and over decades before clear symptoms arise, and today, nearly half of Alzheimer's cases remain unidentified until the latest stages of disease development. One promising early warning sign is a worry expressed by many older adults over their perceived decline in abilities to find words. Until recently, these complaints were brushed off as signs of normal aging. However, new research shows that these "word-finding" difficulties may in fact be linked to early changes in the brain associated with Alzheimer's disease.
Unfortunately, the tools most commonly used in clinical practice are unable to capture subtle changes in language abilities. They often only rely on whether or not a person is able to give a correct answer, neglecting to account, for example, the time taken to get there.
To address existing limitations, our project aims to assemble existing state-of-the-art tasks of language measurement and combine them into a single, gold standard battery which we will promote the use of in clinical practice. It will be aimed at detecting subtle changes in speech and naming abilities, adapting in real time to performance and will be completable on a tablet and provide instantaneous results.
Over the next five years, we will develop this new tool and examine its performance and attributes in comparison to existing methods and self-reported concerns, notably how accurately it can detect underlying brain changes linked to Alzheimer's disease.
Our work will result in a freely available, scientifically validated, gold standard method to detect and monitor Alzheimer's disease at its earliest stages of development. When interventions are most likely to make a difference. This new tool should return power to clinicians, but more importantly, older adults expressing concerns about their perceived declining abilities.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Marier, Anna
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~